Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
IVDs
|
Imaging & IT
|
Cardiovascular
|
Orthopaedics
|
Surgical & Wound care
|
Cellular & Genetic
|
Neurological
|
Other
|
clinica
Market Sector
St Jude: CE mark for Genesis migraine therapy the "starting point" of new neurostim opportunity
08 September 2011
St Jude Medical is confident that its Genesis peripheral nerve stimulation (PNS) therapy, which is now CE marked for treating chronic migraine, will play a significant role in driving the company's future growth. This is in spite of uncertainty ...
 
Quarterly results round-up: Boston still on road to recovery, Thermo Fisher and Zimmer solid
28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
Response Genetics CEO steps down to focus on R&D
26 July 2011
Kathleen Danenberg has quit her position as CEO of personalised medicine firm Response Genetics, but will stay at the company as executive scientific and technology officer. Ms Danenberg will also remain on Response's board of directors. The ...
 
Stryker’s Wingspan clipped by study showing higher stroke risk versus drug therapy
08 September 2011
Stryker’s brain stent system Wingspan has been dealt a blow after a study found that the device, when used to treat clogged arteries in the brain, was linked with an increased risk of stroke and death compared with drug therapy alone. The findings ...
St Jude picks up Medtronic's GPO slack with new contract
26 July 2011
St Jude Medical has taken over a group purchasing organisation (GPO) contract previously held by rival Medtronic. The news comes months after Medtronic cancelled several large GPO contracts, leading to suggestions that other big players might also ...
 
Quarterly results round-up: Boston still on road to recovery, Thermo Fisher and Zimmer solid
28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
NICE hones UK hip fracture care – “surgery needed within first, second day”
23 June 2011
In a sobering review of UK hip fracture care, the National Institute for Health and Clinical Excellence (NICE) has issued guidelines that seek to ensure that patients are operated on the same day of admission or the following day. Citing evidence ...
 
Nervomatrix's targeted neurostimulator gets FDA nod
11 January 2011
NervoStim, an auto-targeting neurostimulation device developed by Israeli firm Nervomatrix for the treatment of lower back pain, has received 510(k) clearance from the US FDA. The system comprises a scanner that identifies the areas responsible for ...
ALS: Synapse's breathing simulation device gets humanitarian approval, Brainstorm initiates stem cell trial
12 October 2010
The US FDA has granted a humanitarian use device approval for Synapse Biomedical's Neurx diaphragm pacing system (DPS) in amyotrophic lateral sclerosis (ALS). The device can be used to simulate a breathing motion in ALS patients who have ...
 
Toumaz sets up JV, readies for US launch of wireless patient monitoring "plaster"
14 July 2011
Toumaz has established a US-based joint venture with private equity firm California Capital Equity as part of its plan to launch its new Sensium digital patient monitoring plaster in the world's biggest medtech market. The disposable plaster, which ...
Mauna Kea launches IPO to fund microscopic imaging technology
21 June 2011
French endomicroscopy specialist Mauna Kea Technologies is looking to raise around €39m ($56m) in its initial public offering on the NYSE Euronext exchange in Paris. The proceeds will enable the firm to ramp up worldwide sales of its flagship ...
 
Michael Mussallem: how innovations will spur cardio industry
15 September 2009
Joseph Harvey

It is not yet apparent what the next game-changing technology in the cardiovascular market will be, says Edwards Lifesciences ’ CEO Michael Mussallem. “Currently people are projecting moderate growth for the market. What I would suggest is ...

 
Successor at Medtronic must choose how to ride out the bumps
23 February 2011
Ashley Yeo

Bill Hawkins’ yet-to-be-appointed successor at Medtronic may be taking over at what is seen as a bad time for the group and the CRM/cardiovascular industry. But the burning question is who will the new chairman and CEO be? The announcement yesterday ...

 
Out of joint: Japan must nurture markets for innovative technologies
23 June 2011
Japan w ants to develop its medtech industry. So how well does it support the technologies in which it already has a stake? If one was look into the field of joint navigation for an answer, they would find that the response is “Not very well”, ...
 Successor at Medtronic must choose how to ride out the bumps...   The feeling’s mutual: Corin, Stryker end US Cormet distribut...
Philips to unveil Guardian for wireless hospital monitoring
01 March 2011
Philips is to launch its new Guardian software, designed to simplify wireless patient monitoring in hospitals, this year. The firm's marketing director for general care, Andreas Bindszus, spoke to Madeleine Armstrong about the advantages of the ...
Successor at Medtronic must choose how to ride out the bumps
23 February 2011
Bill Hawkins’ yet-to-be-appointed successor at Medtronic may be taking over at what is seen as a bad time for the group and the CRM/cardiovascular industry. But the burning question is who will the new chairman and CEO be? The announcement yesterday ...

Drug screening newcomers seek partners at BPE 2009
27 October 2009
Joseph Harvey

The annual BioPartnering Europe conference in London, UK, presents a networking opportunity for biotech and lifesciences firms both large and small. Joseph Harvey attended the event earlier this month to meet two young European companies that have ...

 
Clinica's MedTech Ventures: Issue 36
28 October 2009

I recently visited Norway with senior business reporter Joseph Harvey to uncover some of the hidden medtech gems there. These were not too hard to find, considering that the country's public healthcare system – which is strongly supportive of ...

 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm